Literature DB >> 15003810

Coxsackieviral-mediated diabetes: induction requires antigen-presenting cells and is accompanied by phagocytosis of beta cells.

Marc S Horwitz1, Alex Ilic, Cody Fine, Balaji Balasa, Nora Sarvetnick.   

Abstract

Epidemiological studies have associated coxsackie B virus (CBV) with the development of insulin-dependent diabetes mellitus (IDDM) in humans. Infections of genetically susceptible mice with CBV strain 4 (CB4) induce autoimmune diabetes. Herein, we demonstrate that in mice, CB4 infection of insulin-producing pancreatic beta cells does not directly cause beta cell death. Instead, we observed the phagocytosis of beta cells by macrophages following infection. Further, antigen-presenting cells isolated from CB4-infected mice induced diabetes upon adoptive transfer. Therefore, the specificity of CB4 for infection of beta cells leads indirectly to the development of IDDM. This generalized mechanism suggests that macrophages are the initiating pathogenic cell type during virus-mediated autoimmune diabetes and that multiple environmental agents specific for beta cells could cause IDDM.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15003810     DOI: 10.1016/j.clim.2003.09.014

Source DB:  PubMed          Journal:  Clin Immunol        ISSN: 1521-6616            Impact factor:   3.969


  29 in total

Review 1.  Immune cell crosstalk in type 1 diabetes.

Authors:  Agnès Lehuen; Julien Diana; Paola Zaccone; Anne Cooke
Journal:  Nat Rev Immunol       Date:  2010-07       Impact factor: 53.106

2.  Diabetes acceleration or prevention by a coxsackievirus B4 infection: critical requirements for both interleukin-4 and gamma interferon.

Authors:  David V Serreze; Clive Wasserfall; Eric W Ottendorfer; Michael Stalvey; Melissa A Pierce; Charles Gauntt; Brian O'Donnell; James B Flanagan; Martha Campbell-Thompson; Tamir M Ellis; Mark A Atkinson
Journal:  J Virol       Date:  2005-01       Impact factor: 5.103

Review 3.  Type 1 diabetes: A predictable disease.

Authors:  Kimber M Simmons; Aaron W Michels
Journal:  World J Diabetes       Date:  2015-04-15

4.  Dysregulated TLR3-dependent signaling and innate immune activation in superoxide-deficient macrophages from nonobese diabetic mice.

Authors:  Maria C Seleme; Weiqi Lei; Ashley R Burg; Kah Yong Goh; Allison Metz; Chad Steele; Hubert M Tse
Journal:  Free Radic Biol Med       Date:  2012-02-04       Impact factor: 7.376

Review 5.  Redox-Sensitive Innate Immune Pathways During Macrophage Activation in Type 1 Diabetes.

Authors:  Ashley R Burg; Hubert M Tse
Journal:  Antioxid Redox Signal       Date:  2017-11-27       Impact factor: 8.401

6.  Toll-like receptor 3 is critical for coxsackievirus B4-induced type 1 diabetes in female NOD mice.

Authors:  Kelly D McCall; Jean R Thuma; Maria C Courreges; Fabian Benencia; Calvin B L James; Ramiro Malgor; Noriko Kantake; William Mudd; Nathan Denlinger; Bret Nolan; Li Wen; Frank L Schwartz
Journal:  Endocrinology       Date:  2014-11-25       Impact factor: 4.736

Review 7.  Do viral infections protect from or enhance type 1 diabetes and how can we tell the difference?

Authors:  Urs Christen; Matthias G von Herrath
Journal:  Cell Mol Immunol       Date:  2011-01-24       Impact factor: 11.530

8.  Enterovirus infection of human beta-cells activates dendritic cells and triggers innate antiviral responses: are enteroviruses convicted now?

Authors:  Urs Christen
Journal:  Diabetes       Date:  2010-05       Impact factor: 9.461

Review 9.  Can we learn from viruses how to prevent type 1 diabetes?: the role of viral infections in the pathogenesis of type 1 diabetes and the development of novel combination therapies.

Authors:  Matthias von Herrath
Journal:  Diabetes       Date:  2009-01       Impact factor: 9.461

10.  Phagocytosis of enterovirus-infected pancreatic beta-cells triggers innate immune responses in human dendritic cells.

Authors:  Barbara M Schulte; Matthijs Kramer; Marleen Ansems; Kjerstin H W Lanke; Neeltje van Doremalen; Jon D Piganelli; Rita Bottino; Massimo Trucco; Jochem M D Galama; Gosse J Adema; Frank J M van Kuppeveld
Journal:  Diabetes       Date:  2010-01-13       Impact factor: 9.461

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.